Alongside Boukhzar et al., Bellinger et al. reported an altered expression of SELENOP and GPx4 in survival nigral cells and dystrophic putamen dopaminergic fibers in Parkinson’s disease patients, suggesting that different selenoproteins may be useful as complementary biomarkers of PD [105]. This evidence concerns the gene SELENOS and Parkinson disease.